Specifically, the company states that FDA-approved GLP-1/GIP medications for weight loss and type 2 diabetes, including Ozempic, Wegovy, Zepbound, and Mounjaro, "may also be eligible for coverage." The company further states that while they "assist with prior authorizations and prescription submissions," they "do not bill insurance directly." This distinction is important: the compounded GLP-1 program itself is described as a cash-pay arrangement, but the company also facilitates access to FDA-approved branded medications that may have insurance pathways
botbargain Added 6d ago On Jul 28, 2026 botbargain received the code "SOWNOW" from Eden Brothers
They are less likely to cause hypoglycemia and have a neutral effect on weight
doi: 10.3389/fendo.2023.1122709 51 ZhangNLiCGuoYWuHC
Injured people may experience similar side effects from semaglutide, liraglutide and tirzepatide which are the active ingredients of the GLP-1 RA drugs in the Wegovy MDL